Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Muscarinic receptor ligand selected for further study

July 12, 1996

First demonstration of cellular mechanism of human oral tolerance

July 12, 1996

First approval of SmithKline Beecham's ReQuip in U.K.

July 12, 1996

Lundbeck's Serdolect reaches first market

July 12, 1996

Pharmacia & Upjohn's dopamine D4 receptor ligands

July 12, 1996

Potent, selective mGluR2 agonist from Lilly

July 12, 1996

Potential CNS disorders treatment from Janssen

July 12, 1996

Melatonin effective for jet lag/shift lag

July 12, 1996

Lilly describes heterocyclic tachykinin antagonists

July 12, 1996

Faulding's Kadian approved by FDA

July 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...